NEW YORK (GenomeWeb) – A partnership between three medical and academic institutions in Heidelberg has made molecular tumor profiling available to cancer patients across Germany, impacting the treatment of many.
The initiative involves Heidelberg University Hospital's Center for Molecular Pathology, the National Center for Tumor Diseases' (NCT) Precision Oncology Program, and the German Cancer Research Institute' (DKFZ) Center for Personalized Oncology.